253 related articles for article (PubMed ID: 28151757)
1. Drug therapy of advanced cutaneous squamous cell carcinoma: is there any evidence?
Ribero S; Stucci LS; Daniels GA; Borradori L
Curr Opin Oncol; 2017 Mar; 29(2):129-135. PubMed ID: 28151757
[TBL] [Abstract][Full Text] [Related]
2. Cemiplimab for the treatment of advanced cutaneous squamous cell carcinoma.
Hernández-Guerrero T; Doger B; Moreno V
Drugs Today (Barc); 2019 Aug; 55(8):485-494. PubMed ID: 31461085
[TBL] [Abstract][Full Text] [Related]
3. Prospects for personalized targeted therapies for cutaneous squamous cell carcinoma.
Mavropoulos JC; Aldabagh B; Arron ST
Semin Cutan Med Surg; 2014 Jun; 33(2):72-5. PubMed ID: 25085665
[TBL] [Abstract][Full Text] [Related]
4. The Promise of Genomics and the Development of Targeted Therapies for Cutaneous Squamous Cell Carcinoma.
Harwood CA; Proby CM; Inman GJ; Leigh IM
Acta Derm Venereol; 2016 Jan; 96(1):3-16. PubMed ID: 26084328
[TBL] [Abstract][Full Text] [Related]
5. Update on the anti-programmed cell death-1 receptor antibodies in advanced cutaneous squamous-cell carcinoma.
Benzaquen M
Dermatol Ther; 2020 May; 33(3):e13325. PubMed ID: 32208547
[TBL] [Abstract][Full Text] [Related]
6. Systemic therapy for advanced cutaneous squamous cell carcinoma.
Fitzgerald K; Tsai KK
Semin Cutan Med Surg; 2019 Mar; 38(1):E67-E74. PubMed ID: 31051028
[TBL] [Abstract][Full Text] [Related]
7. Targeted therapy for cutaneous oncology: a review of novel treatment options for non-melanoma skin cancer: part II.
Walls B; Jordan L; Diaz L; Miller R
J Drugs Dermatol; 2014 Aug; 13(8):955-8. PubMed ID: 25116974
[TBL] [Abstract][Full Text] [Related]
8. Advanced cutaneous squamous cell carcinoma: how is it defined and what new therapeutic approaches are available?
Soura E; Gagari E; Stratigos A
Curr Opin Oncol; 2019 Sep; 31(5):461-468. PubMed ID: 31394558
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy in the management of advanced cutaneous squamous cell carcinoma in organ transplant recipients: theoretical and practical considerations.
Martinez JC; Otley CC; Okuno SH; Foote RL; Kasperbauer JL
Dermatol Surg; 2004 Apr; 30(4 Pt 2):679-86. PubMed ID: 15061855
[TBL] [Abstract][Full Text] [Related]
10. Comparative efficacy analysis identifies immune checkpoint blockade as a new survival benchmark in advanced cutaneous squamous cell carcinoma.
Petzold A; Steeb T; Wessely A; Schatton T; Berking C; Heppt MV
Eur J Cancer; 2022 Jul; 170():42-53. PubMed ID: 35594611
[TBL] [Abstract][Full Text] [Related]
11. The Role of Systemic Therapy in Advanced Cutaneous Squamous Cell Carcinoma.
McMullen CP; Ow TJ
Otolaryngol Clin North Am; 2021 Apr; 54(2):343-355. PubMed ID: 33583597
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and Tolerance of Cetuximab Alone or Combined with Chemotherapy in Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: An Open Study of 14 Patients.
Dereure O; Missan H; Girard C; Costes V; Guillot B
Dermatology; 2016; 232(6):721-730. PubMed ID: 28384639
[TBL] [Abstract][Full Text] [Related]
13. Real-world Treatment Patterns and Outcomes with Systemic Therapies in Unresectable Locally Advanced and Metastatic Cutaneous Squamous Cell Carcinoma in Germany.
Kramb F; Doerfer C; Meiwes A; Ramakrishnan K; Eigentler T; Garbe C; Keim U; Leiter U
Acta Derm Venereol; 2022 Jan; 102():adv00637. PubMed ID: 34842930
[TBL] [Abstract][Full Text] [Related]
14. Where do we stand with immune checkpoint blockade for advanced cutaneous squamous cell carcinoma? A systematic review and critical appraisal of the existing evidence.
Steeb T; Wessely A; Heppt F; Harlaß M; Berking C; Heppt MV
Br J Dermatol; 2020 Aug; 183(2):380-382. PubMed ID: 32068244
[No Abstract] [Full Text] [Related]
15. Novel treatments using PD1 inhibitors for advanced and metastatic cutaneous squamous cell carcinoma.
Pezeshki S; Hemmati S; Rezaei N
Expert Rev Anticancer Ther; 2020 Oct; 20(10):819-822. PubMed ID: 32852235
[No Abstract] [Full Text] [Related]
16. Molecular and immune targets in cutaneous squamous cell carcinoma.
Galambus J; Tsai KY
Mol Carcinog; 2023 Jan; 62(1):38-51. PubMed ID: 36000298
[TBL] [Abstract][Full Text] [Related]
17. Best practice in the treatment of advanced squamous cell lung cancer.
Ang YL; Tan HL; Soo RA
Ther Adv Respir Dis; 2015 Oct; 9(5):224-35. PubMed ID: 25902866
[TBL] [Abstract][Full Text] [Related]
18. Review of systemic agents in the treatment of advanced cutaneous squamous cell carcinoma.
Petersen ET; Ahmed SR; Chen L; Silapunt S; Migden MR
Future Oncol; 2019 Sep; 15(27):3171-3184. PubMed ID: 31382778
[TBL] [Abstract][Full Text] [Related]
19. Update on the Use and Treatment of Targeted Molecular Inhibitors for Locally Advanced and Metastatic Non-Melanoma Skin Cancers.
Odueyungbo M; Ratner D
Dermatol Surg; 2016 Jan; 42 Suppl 1():S49-56. PubMed ID: 26730974
[TBL] [Abstract][Full Text] [Related]
20. Oral therapy for nonmelanoma skin cancer in patients with advanced disease and large tumor burden: a review of the literature with focus on a new generation of targeted therapies.
Rudnick EW; Thareja S; Cherpelis B
Int J Dermatol; 2016 Mar; 55(3):249-58; quiz 256, 258. PubMed ID: 26566923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]